Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | -$1.32M | -5.6K | -93.33% | $234.85 | 400 | Feb 5, 2024 | Common Stock | 5.6K | $52.69 | Direct | F2 |
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | -$1.41M | -6K | -40% | $234.85 | 9K | Feb 5, 2024 | Common Stock | 6K | $87.69 | Direct | F3 |
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | -$1.06M | -4.5K | -50% | $234.85 | 4.5K | Feb 5, 2024 | Common Stock | 4.5K | $87.69 | Direct | F3 |
transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | -$1.06M | -4.5K | -100% | $234.85 | 0 | Feb 5, 2024 | Common Stock | 4.5K | $87.69 | Direct | F3 |
Id | Content |
---|---|
F1 | Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. |
F2 | Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
F3 | Option will vest based on achievement of certain performance criteria relating to earnings growth. |